Integrative pathway analysis across humans and 3D cellular models identifies the p38 MAPK-MK2 axis as a therapeutic target for Alzheimer's disease.
Naderi Yeganeh P, Kwak SS, Jorfi M, Koler K, Kalatturu T, von Maydell D, Liu Z, Guo K, Choi Y, Park J, Abarca N, Bakiasi G, Cetinbas M, Sadreyev R, Griciuc A, Quinti L, Choi SH, Xia W, Tanzi RE, Hide W, Kim DY.
Naderi Yeganeh P, et al. Among authors: kim dy.
Neuron. 2024 Nov 25:S0896-6273(24)00800-6. doi: 10.1016/j.neuron.2024.10.029. Online ahead of print.
Neuron. 2024.
PMID: 39610246